Discontinued — last reported Q4 '22
Insmed State remained flat by 0.0% to -$6.75K in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.9%, from -$7.25K to -$6.75K. Over 4 years (FY 2021 to FY 2025), State shows an upward trend with a -54.2% CAGR.
An increase in deferred tax assets suggests future tax benefits, while an increase in deferred tax liabilities suggests future tax payments.
Represents the portion of state and local income tax expense that is deferred to future periods due to temporary differe...
Commonly reported by large U.S. corporations with multi-state operations; peers typically disclose this in the tax footnote.
other_deferred_state_and_local_income_tax_expense_benefit| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | -$612.00K | -$244.00K | -$41.00K | -$29.00K | -$27.00K |
| YoY Change | — | +60.1% | +83.2% | +29.3% | +6.9% |